Trials / Conditions / Diffuse Large B-Cell Lymphoma Unclassifiable
Diffuse Large B-Cell Lymphoma Unclassifiable
3 registered clinical trials studyying Diffuse Large B-Cell Lymphoma Unclassifiable.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Polatuzumab Vedotin, Rituximab, Ifosfamide, Carboplatin, and Etoposide (PolaR-ICE) as Initial Salvage Therapy NCT04665765 | City of Hope Medical Center | Phase 2 |
| Suspended | Nivolumab and Combination Chemotherapy in Treating Participants With Diffuse Large B-Cell Lymphoma NCT03704714 | Northwestern University | Phase 1 / Phase 2 |
| Completed | Smart Start: A Phase II Study of Rituximab, Lenalidomide, and Ibrutinib NCT02636322 | M.D. Anderson Cancer Center | Phase 2 |